In this study, we profiled BCL2L13 across 33 cancer types in the Cancer Genome Atlas (TCGA), and found that its mRNA expression is significantly reduced in ccRCC and pRCC. The gene discussed is BCL2L13; the disease is nonpapillary renal cell carcinoma.